BRAC Bank PLC has launched the country’s first SME innovation lab, titled “Finnovision”, aimed at helping small businesses grow and thrive through the adoption of innovative solutions.

What started as a fun peek into ancestry quickly turned into life-altering information for many of these people. The stories ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

Study at the University of Colorado Anschutz Cancer Center builds on preclinical data showing that cirtuvivint plus PARP inhibition overcame resistance in preclinical models of high‑grade serous ovari ...

The Oscar-winning actress underwent a preventative double mastectomy in February 2013 after learning that she had a high risk ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

Zydus Lifesciences has partnered with US-based Myriad Genetics to launch diagnostic tests assessing cancer risk in India, aiming to expand access to precision diagnostics.

Zydus partners with Myriad Genetics to introduce advanced cancer-risk assessment tests, enhancing precision diagnostics in India.

Angelina Jolie lost multiple women in her family to the fatal condition, including her mother, leading her to take preventive ...

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...

The agency said that although Akeega with prednisone improved outcomes in all patients with HRR mutations, the benefits were driven by those with BRCA2 mutations.

More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...